Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6
Keywords:
Antiseizure medication
Cannabidiol
Epilepsy
Focal seizures
Medication-resistant seizures
Tuberous sclerosis complex
Note:
Creative Commons Attribution-NonCommercial License
Citation:
Wu JY, Cock HR, Devinsky O, Joshi C, Miller I, Roberts CM, et al. Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6. Epilepsia. 2022;63:1189–1199.
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.